Cargando…
Correction: Laboratory-based intermountain validated exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305470/ https://www.ncbi.nlm.nih.gov/pubmed/32540956 http://dx.doi.org/10.1136/bmjresp-2019-000450corr1 |
Ejemplares similares
-
Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020) -
The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk
por: Blagev, Denitza P., et al.
Publicado: (2018) -
Validation of the Intermountain Risk Score and Get with the Guidelines—Heart Failure Score in predicting mortality
por: Engelsgjerd, Erik K, et al.
Publicado: (2021) -
Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010) -
Correction to: Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease
por: Joo, Hyonsoo, et al.
Publicado: (2021)